# Netrin-1 & Hepatocellular Carcinoma HCC

> **NCT04766736** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 320 (estimated)

## Conditions studied

- HCC

## Interventions

- **PROCEDURE:** Quantification of netrin-1 signals by antibody-based approaches

## Key facts

- **NCT ID:** NCT04766736
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766736, "Netrin-1 & Hepatocellular Carcinoma HCC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04766736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*